Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Global Anticoagulants Market: Size, Trends & Forecasts (2016-2020)
By Daedal Research
Scope of the Report The report entitled “Global Anticoagulants Market: Size, Trends & Forecasts (2016-2020)” provides an analysis of the global anticoagulants market with detailed descripti...
May 2016 $ 800
United States Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Health expenditure in the US is forecast to increase by more than 50% over the next decade. A common misconception is that drug companies and medicine price hikes are accountable for this rise and the downward pressure it allege...
May 2016 $ 1295
Sweden Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Pharmaceutical companies will face an increasingly tough drug pricing environment in Sweden. The government will expand its use of pharmacoeconomic evaluations in order to provide appropriate justification of current expenditure...
May 2016 $ 1295
Lithuania Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Lithuania's pharmaceutical and healthcare market represents a modest prospect for investment from multinational firms. A rising burden of chronic disease will translate into an increase in demand and sales; however, fiscal polic...
May 2016 $ 1295
Lebanon Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: We believe the Lebanese government's focus on improving healthcare access and quality across the country coupled with a rising disease burden and relatively high per capita spending will drive the demand of high-value prescripti...
May 2016 $ 1295
Latvia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Latvia's pharmaceutical and healthcare markets will be shaped by the country's ongoing fiscal austerity measures. Already severely underfunded, the healthcare sector is facing additional cuts which are proving highly unpopular w...
May 2016 $ 1295
Jordan Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Jordan's pharmaceutical and healthcare markets have enormous potential to develop into attractive investment prospects for multinational pharmaceutical companies. The country's domestic pharmaceutical industry will continue to s...
May 2016 $ 1295
Japan Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: There will be opportunities for haemophilia products within the Japan pharmaceutical market. The country has the third largest population of haemophilia patients in Asia, high levels of adherence and an extensive health insuranc...
May 2016 $ 1295
Guatemala Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Due to its small market size and low per capita pharmaceutical spending, the Guatemalan pharmaceutical market will continue to attract limited multinational drugmaker investment in 2016. Generic drugmakers in Latin America will ...
May 2016 $ 1295
Greece Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The government's focus on increasing the consumption of generic medicines and poor financial administration highlights Greece as a challenging market for innovative drugmakers. Despite an urgent need to reduce pharmaceutical and...
May 2016 $ 1295
Ghana Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The Ghanaian government will retain its support towards domestic pharmaceutical manufacturers in the country, in hope of achieving status as the Economic Communities of West African States' hub for pharmaceutical and healthcare ...
May 2016 $ 1295
Gabon Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Gabon's pharmaceutical and healthcare markets will be challenged by insufficient healthcare infrastructure, the lack of domestic manufacturing capabilities and a weakening oil sector. The country suffers from a small pharmaceuti...
May 2016 $ 1295
Croatia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Reforms to Croatia's healthcare system have been laid out by the new coalition government's Minister of Health. There has been strong opposition within the government over these proposals; however, the country's healthcare is in...
May 2016 $ 1295
Kuwait Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: With the recent oil strike representing a harbinger of significant political and economic turbulence ahead, the stability of its health and pharmaceutical sectors will depend on Kuwait's integration with neighbouring Gulf states...
May 2016 $ 1295
Kenya Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Many emerging market economies are increasingly exposed to the negative effect of sustained lower commodity prices. This is putting downward pressure on government finances and, as a consequence, healthcare budgets. We neverthel...
May 2016 $ 1295
Indonesia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The Indonesian medical landscape will see a larger presence of private healthcare providers over medium term. Underpinning this expansion is the robust prospects for the industry, with the introduction of a Coordination of Benef...
May 2016 $ 1295
France Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Despite the ongoing recovery in some high frequency indicators, subdued economic growth in France relative to regional peers will continue to weigh on the French government spending potential, posing downside risks to our pharma...
May 2016 $ 1295
Estonia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Estonia's healthcare system is much more mature than its Central and Eastern European peers, but given the country's limited resources, the country is less appealing to pharmaceutical companies. Drugmakers can expect to see cons...
May 2016 $ 1295
Ecuador Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Chinese investment in Ecuador's pharmaceutical and healthcare sector will continue to be pertinent for the country in order for it to meet the increasing demand of medicines within its public healthcare sector. Foreign generic d...
May 2016 $ 1295
Cameroon Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Although Cameroon's economic growth is expected to remain on track driven by public-private partnerships in strategic infrastructure projects, the country's pharmaceutical and healthcare sector will remain dependent on private o...
May 2016 $ 1295
Australia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Drugmakers operating in Australia will face an increasingly challenging business environment as the Sixth Pharmacy Community Agreement's measures come into effect. This includes a 5% price cut to medicines listed on the F1 formu...
May 2016 $ 1295
Global Migraine Market Report: 2016 Edition
By Koncept Analytics
Migraine is a common neurovascular disorder that is characterized by throbbing headaches and is commonly associated with other neurological symptoms, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraines are thought to ...
May 2016 $ 800
Generic Drugs Industry Forecasts - China Focus
By AMID
This study focuses on China's Generic Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transfor...
May 2016 $ 1000
Depression Treatment Drugs Industry Forecasts - China Focus
By AMID
This study focuses on China's Depression Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China...
May 2016 $ 1000
Kazakhstan Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The mid-term outlook for Kazakhstan's pharmaceutical and healthcare markets is mixed. The healthcare system is set to improve, with the introduction of a public health insurance system and e-health technology; however, the forma...
May 2016 $ 1295